Sinopharm Group Co. Ltd. (HKG:1099)
21.14
-0.20 (-0.94%)
At close: Feb 27, 2026
Sinopharm Group Revenue
Sinopharm Group had revenue of 145.44B CNY in the quarter ending September 30, 2025, a decrease of -1.37%. This brings the company's revenue in the last twelve months to 573.56B, down -3.29% year-over-year. In the year 2024, Sinopharm Group had annual revenue of 584.51B, down -2.02%.
Revenue (ttm)
573.56B CNY
Revenue Growth
-3.29%
P/S Ratio
0.11
Revenue / Employee
5.30M CNY
Employees
108,217
Market Cap
65.97B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 584.51B | -12.06B | -2.02% |
| Dec 31, 2023 | 596.57B | 44.42B | 8.05% |
| Dec 31, 2022 | 552.15B | 31.10B | 5.97% |
| Dec 31, 2021 | 521.05B | 64.64B | 14.16% |
| Dec 31, 2020 | 456.41B | 31.14B | 7.32% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 160 Health International | 698.59M |
| ETHK Labs | 3.37B |
| Sipai Health Technology | 3.75B |
| China Health Group | 39.87M |
| Charmacy Pharmaceutical | 4.65B |
| ClouDr Group | 2.47B |
| Sinco Pharmaceuticals Holdings | 2.73B |
| Ziyuanyuan Holdings Group | 575.61M |
Sinopharm Group News
- 5 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 5 years ago - Week In Review: WHO Close To Approving Global Use For 2 China COVID-19 Vaccines - Seeking Alpha
- 5 years ago - Diversifying Into Top-Ranked Sinopharm - Seeking Alpha
- 5 years ago - Week In Review: Sinopharm Transfers $4.6 Billion In Assets Including Two COVID-19 Vaccines - Seeking Alpha
- 5 years ago - Week In Review: Eluminex Raises $50 Million For Ophthalmology Drugs - Seeking Alpha
- 6 years ago - 6 Stocks I Just Bought For My Retirement Portfolio - Hong Kong Edition - Seeking Alpha
- 6 years ago - Go Long On SinoPharm Group's HKEX Ticker 1099:HK - Seeking Alpha